Skip to main content
. 2018 Oct 15;9:588. doi: 10.3389/fendo.2018.00588

Table 1.

Hepatokines and exercise training.

Hepatokine Effect on metabolism and NAFLD Secretion in NAFLD and obesity Changes of secretion or blood concentration by exercise training
Experimental model Clinical study
Significance Protocol (ref) Significance Protocols (ref)
Adropin Positive Decreased Increase (plasma) Ergometer
55 min, 3 days/weeks, 8 weeks (D42).
Aerobic training
90 min, 3-5 days/weeks. 12 weeks (D43)
ANGPTL4 Negative/
positive
Decreased Increase (liver mRNA) Treadmill
60 min, single bout (D55)
Increase (plasma) One-legged cycling
60-180 min, single bout (D 45)
Endurance exercise
120 min, single bout (D54)
Knee-extensor exercise
120 min, single bout (D44)
SHBG Positive Decreased Mostly Increase (serum) Walking
30-45 min, daily, 3 weeks s with diet therapy (D64)
Line dance
60 min, 3 days/weeks, 16 weeks (D65)
Fetuin A Negative Increased Increase up to normal level (serum) Treadmill
60 min, 5 days/weeks, 16 (D80)
Decrease (serum, plasma) Ergometer
60 min, 5 days/weeks, 12 weeks (D75, D76)
Walking
60 min, daily, 1 weeks (D77)
FGF21 Positive Increased Increase in acute exercise (serum and liver mRNA) Treadmill
30 min, single bout (E12)
*Running wheel
8 weeks (E13)
Increase (plasma) Treadmill running
60 min, single bout (D79)
Treadmill running
30 min, single bout (E12)
Hepassocin Negative Increased
LECT2 Negative Increased No change (plasma) Treadmill running
60 min, single bout (D79)
RBP4 Negative Increased Probably decrease Treadmill
60 min, 5 days/weeks, 10 weeks (D99)
Decrease (serum, plasma) Resistance training
5 days/weeks, 12 weeks (D98)
Stepping training
60 min, 3 days/weeks, 10 weeks (D100)
Selenoprotein P Negative Increased No change (plasma and liver mRNA) Treadmill
30 min, 6 days/weeks, 1 weeks (F3)
Treadmill
30 min, 5 days/weeks, 4 weeks (F3)
No change (plasma) Treadmill running
60 min, single bout (D79)
Military training
360 min, 5 days/weeks, 12 weeks (F2)
Cycling and walking
30-45 min, 3 days/weeks, 8 weeks (F3)

*non-significant protocol.